Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and Response-Based Radiation for Localized NGGCT
NCT04684368Phase 2Recruiting
- Sponsor
- Children's Oncology Group
- Start
- Jul 2021
- Primary completion
- Dec 2029
- Modality
- DNA Intercalators/Alkylators
- Countries
- 4
01
Overview
A Phase 2 trial of carboplatin, etoposide, ifosfamide, thiotepa in central nervous system germ cell tumor, sponsored by Children's Oncology Group. Started Jul 2021; status: recruiting.
02
Drugs
carboplatinetoposideifosfamidethiotepa
03
Conditions
central nervous system germ cell tumor
Beyond the preview
Go deeper on NCT04684368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04684368.